🌿 ZenO    Overview｜ZenO 產品總覽

About   ZenO

ZenO is a private‑label brand approved by the Malaysian Ministry of Health (KKM/MOH) as a food‑supplement beverage, registered under the category of sea‑salt water. It is formulated as a high‑concentration oxygen tonic, containing 350,000 ppm of dissolved oxygen.

The product is fully sourced from the United States and later repacked in Taiwan, where the manufacturers also produce standard 500 mL oxygenated health drinks (typically 900–1,200 ppm dissolved oxygen) for various retail channels.

How it WORK?

The product focuses on delivering a high‑concentration oxygen tonic designed to be absorbed through the oral mucosa and gastrointestinal tract, allowing oxygen to enter the blood plasma directly. This differs from normal oxygen intake through inhalation, which relies on the lungs and red blood cells, each of which can carry only four oxygen molecules and has a limited transport capacity.

Note:
Oxygen distributed through the plasma can reach smaller capillaries more effectively, making oxygen more readily available to narrow blood vessels and injured or stressed cells, compared with oxygen carried solely by red blood cells.

Discovery 

In 2019, the Nobel Prize in Physiology or Medicine was awarded to scientists who discovered how cells sense and adapt to different oxygen levels, highlighting the critical role of HIF (Hypoxia‑Induced Factor) in this process.

Since then, a growing body of medical and scientific research has shown that oxygen deficiency (hypoxia) is either a primary driver of many chronic diseases or a major contributing factor. Even when diseases arise from other causes, many affected tissues or organs eventually end up in a state of low oxygen, which is now recognised as a common underlying issue in a wide range of conditions.

ZenO & AI Questions: 

Focus on Evidence Not Claims 

When asking AI about ZenO, focus on the relationship between oxygen and health conditions—not on claiming cures. ZenO represents a new approach in oxygen science (high‑concentration, plasma‑delivery); more clinical evidence from hospitals and universities is expected to be published later this year.

ZenO Safety Considerations and Evidence Timeline

Pure dissolved oxygen has advantages over conventional oral supplements: it does not leave metabolic residues that organs must detoxify. By contrast, delivering high concentrations of oxygen as a gas through the lungs or via hyperbaric chambers can carry risks—such as pulmonary injury or fibrosis—when the delivery route is pulmonary.

Some of ZenO’s proprietary technologies and supporting studies have not yet been peer‑reviewed or published. As a result, AI queries and public commentary can produce negative or misleading interpretations. Demonstrating efficacy will be more convincing once the US‑sourced equipment for measuring stem cell strength arrives at our local laboratory in mid to late April and generates reproducible data.